Pyxus Announces the Commencement of Exchange Offer and Consent Solicitation With Respect to its 8.50% Senior Secured Notes due 2027

Pyxus launches $148 million debt exchange with major covenant and collateral changes.

What the company is saying

Pyxus International, Inc. and its subsidiary Pyxus Holdings, Inc. have initiated a private exchange offer for all $148,338,952 outstanding 8.50% Senior Secured Notes due 2027. The company details two tiers of consideration: for notes tendered by November 24, 2026, holders receive $344.37 in common stock (at $3.25 per share) and $675.90 in new floating rate senior secured notes per $1,000 principal; for later tenders by December 10, 2026, the amounts are $327.15 in stock and $642.11 in new notes. The offer is paired with a consent solicitation to amend the indenture, aiming to eliminate most restrictive covenants, remove the change of control repurchase, subordinate the notes to senior debt, and release all collateral. The company emphasizes that these amendments and collateral release require majority and 66 2/3% consent thresholds, respectively. A Transaction Support Agreement, effective November 5, 2026, has been signed with creditors holding 67.9% of Intabex Term Loans, 74.9% of Pyxus Term Loans, and 56.0% of Existing Notes, who have agreed to participate subject to conditions. The tone is procedural and detailed, focusing on transaction mechanics and required approvals rather than promotional language or operational outlook.

What the data suggests

The exchange offer covers $148,338,952 of 8.50% Senior Secured Notes due 2027, with holders able to exchange each $1,000 principal for either $344.37 in stock and $675.90 in new notes (early tender) or $327.15 in stock and $642.11 in new notes (late tender), both at a $3.25 share price. Accrued and unpaid interest will also be paid up to the settlement date, expected December 15, 2026. The amendments sought would strip most covenants, remove the change of control put, subordinate the notes to senior debt, and release collateral, materially reducing protections for any notes not exchanged. The company has secured support from holders of 67.9% of Intabex Term Loans, 74.9% of Pyxus Term Loans, and 56.0% of Existing Notes, but closing requires consents from at least 99% (or 97% if certain conditions are met) of each tranche. The process is contingent on meeting these high participation thresholds, with no evidence yet that the minimums have been reached. The data is specific and transaction-focused, but does not provide broader financial context or pro forma impacts.

Analysis

The announcement is a factual, detailed disclosure of a private exchange offer and consent solicitation for $148.3 million of outstanding notes. The language is procedural and transactional, with no promotional or exaggerated claims about future performance or company prospects. Most forward-looking statements are conditional and relate to the mechanics and timing of the exchange and required consents, not to operational or financial outcomes. The benefits (exchange consideration, amendments) are expected to be realised in the near term, pending consent thresholds, with a settlement date specified as December 15, 2026. There is a large capital structure impact, but the announcement does not claim immediate earnings or operational benefits, nor does it frame the transaction as transformative. No narrative inflation or overstatement is present; the tone is measured and appropriate for the content.

Risk flags

• ●There is significant execution risk: the transaction requires consents from at least 99% of holders of each of the Existing Notes, Pyxus Term Loans, and Intabex Term Loans, a high bar that may be difficult to reach, especially as only 56.0% of Existing Notes are currently committed.
• ●The amendments will eliminate most restrictive covenants, remove the change of control repurchase, subordinate the notes to senior debt, and release all collateral, meaning that any notes not exchanged will lose substantial protections and become effectively unsecured and subordinated, increasing risk for non-participating holders.
• ●The offer is highly dilutive for noteholders, as a material portion of the consideration is paid in common stock at a fixed price, and the company does not disclose the total number of shares to be issued or the pro forma impact on equity holders.
• ●There is no disclosure of the company's current financial condition, liquidity, or pro forma leverage after the exchange, making it impossible to assess whether the transaction will materially improve the balance sheet or simply restructure obligations without addressing underlying risks.
• ●Settlement and completion are subject to multiple conditions, including the execution of a supplemental indenture and the satisfaction or waiver of the minimum participation condition, so there is no certainty the transaction will close as planned.

Bottom line

Pyxus is attempting a major restructuring of its $148.3 million in 8.50% Senior Secured Notes, offering a mix of new notes and equity in exchange for existing debt, with material reductions in covenant and collateral protections for any notes not exchanged. The transaction is contingent on extremely high participation—99% of holders must consent, though this can drop to 97% under certain conditions—and only 56% of noteholders are currently committed. If successful, the deal will significantly alter the capital structure, but the lack of broader financial disclosure leaves the ultimate impact on company health unclear. Non-participating noteholders face sharply reduced protections and subordination. The next key milestone is whether the company can secure the required consents by December 10, 2026. The most important takeaway is that this is a high-stakes, near-term restructuring with substantial implications for both debt and equity holders, but with meaningful execution and residual risk.

Announcement summary

(OTCID: PYYX) Pyxus International, Inc. and its wholly-owned subsidiary, Pyxus Holdings, Inc., have commenced a private offer to exchange any and all of the Issuer's outstanding 8.50% Senior Secured Notes due 2027 for new consideration. For Existing Notes validly tendered at or prior to 5:00 p.m., New York City time, on November 24, 2026 (the Early Tender Time), holders will receive $344.37 in value of Pyxus common stock at a price of $3.25 per share and $675.90 in aggregate principal amount of new floating rate senior secured notes per $1,000 principal amount of Existing Notes. For Existing Notes tendered after the Early Tender Time but at or prior to the Expiration Date (5:00 p.m., New York City time, on December 10, 2026), holders will receive $327.15 in value of common stock at $3.25 per share and $642.11 in aggregate principal amount of new notes per $1,000 principal amount of Existing Notes. The total principal amount outstanding of the Existing Notes is $148,338,952. Eligible holders whose Existing Notes are accepted for exchange will also receive accrued and unpaid interest from the last interest payment date to, but not including, the Settlement Date, which is expected to be December 15, 2026. The Exchange Offer is being made in conjunction with a Consent Solicitation to amend the indenture governing the Existing Notes, including eliminating most restrictive and certain affirmative covenants, eliminating the change of control repurchase obligation, subordinating the Existing Notes to senior indebtedness, and releasing all collateral securing the Existing Notes. The amendments and collateral release require consents from a majority and 66 2/3% of holders, respectively. The Transaction Support Agreement, effective November 5, 2026, was entered into with a group of creditors holding approximately 67.9% of Intabex Term Loans, 74.9% of Pyxus Term Loans, and 56.0% of Existing Notes. The closing of the Exchange Transactions is subject to consents from holders of at least 99% of the outstanding principal amount of each of the Existing Notes, Pyxus Term Loans, and Intabex Term Loans, which may be reduced to 97% for the Existing Notes under certain conditions. Supporting Holders have agreed to exchange their holdings and deliver consents, subject to terms and conditions. Upon receipt of the necessary consents and satisfaction or waiver of conditions, the Supplemental Indenture will be executed to implement the amendments and collateral release. Existing Notes not exchanged will remain outstanding but will be subordinated and, if the collateral release is effectuated, will no longer be secured. The changes will not alter the principal, interest, interest rate, maturity date, or redemption provisions of the Existing Notes.

Disagree with this article?